2014
DOI: 10.1517/17460441.2014.907789
|View full text |Cite
|
Sign up to set email alerts
|

Design and discovery of mushroom tyrosinase inhibitors and their therapeutic applications

Abstract: Although a great number of tyrosinase inhibitors have been published in the literature, none, as of yet, have reached the potency and safety requirements needed to enter clinical trials. The emergence of new in vitro and in vivo tests will finally allow the arrival of new compounds that are more potent and safe.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
30
0
7

Year Published

2016
2016
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 48 publications
(37 citation statements)
references
References 94 publications
0
30
0
7
Order By: Relevance
“…Additionally, ChEIs have been also used in the treatment of glaucoma and myasthenia gravis or as insecticidal agents . On the other hand, tyrosinase (TYR), an enzyme found in melanocytes, catalyzes the rate‐limiting oxidation of tyrosine to melanin, which plays a critical role in the pigmentation of skin, hair, and eyes in animal, undesirable browning of fruits and vegetables, moulting process of insects, and dopamine toxicity in Parkinson's disease (PD) as well as neuronal death in PD and Huntington's diseases . Thus, inhibition of TYR might be a new and quite important target in the treatment of the aforementioned diseases.…”
Section: Introductionmentioning
confidence: 99%
“…Additionally, ChEIs have been also used in the treatment of glaucoma and myasthenia gravis or as insecticidal agents . On the other hand, tyrosinase (TYR), an enzyme found in melanocytes, catalyzes the rate‐limiting oxidation of tyrosine to melanin, which plays a critical role in the pigmentation of skin, hair, and eyes in animal, undesirable browning of fruits and vegetables, moulting process of insects, and dopamine toxicity in Parkinson's disease (PD) as well as neuronal death in PD and Huntington's diseases . Thus, inhibition of TYR might be a new and quite important target in the treatment of the aforementioned diseases.…”
Section: Introductionmentioning
confidence: 99%
“…10 Topical agents, chemical peels, cryotherapy and laser therapy are the main options for the treatment of skin hyperpigmentation. 11,12 However, the most popular treatment utilized for depigmentation is the topical cosmetics containing hydroquinone (HQ), the main therapeutic options in their formulation substances, as well as arbutin, azelaic acid, and kojic acid, 13,14 other agents acting through different mechanisms. 15,16 The effectiveness of HQ is related directly to the concentration of the preparation in the vehicle used to the chemical stability of the final product.…”
Section: Introductionmentioning
confidence: 99%
“…Furthermore, the extensive economic value of the inhibitors and different inhibitor compounds derived especially from natural products or synthetic compounds, have increased this interest. 11,14,15 Since hydroquinone (HQ), kojic acid (KA) and ascorbic acid (AA) are simple structures, these molecules are an attractive target for chemical stability studies due to their structure-property and design of better formulations. Therefore, in this work the increase of chemical stability of HQ by thiol antioxidant compound is displayed using experimental and theoretical methods.…”
mentioning
confidence: 99%
“…On the other hand, tyrosinase (TYR; polyphenol oxidase or oxygen oxidoreductase, EC 1.14.18.1) catalyzes the ratelimiting oxidation of tyrosine to melanin, which plays a critical role in pigmentation of skin related to melanoma, undesirable browning of fruits and vegetables, molting process of insects, and dopamine toxicity in Parkinson's disease (PD) as well as neuronal death in PD and Huntington's disease [3,4]. Therefore, inhibition of TYR is a new target and quite important for treatment of the aforementioned diseases.…”
Section: Introductionmentioning
confidence: 99%